Literature DB >> 10952825

Sensitivity, specificity, and predictive accuracies of non-invasive tests, singly and in combination, for diagnosis of hibernating myocardium.

G La Canna1, S H Rahimtoola, O Visioli, R Giubbini, O Alfieri, M Zognio, E Milan, C Ceconi, M Gargano, R Lo Russo, R Ferrari.   

Abstract

OBJECTIVE: To determine the best test(s) for predicting functional recovery of hibernating myocardium after reperfusion.
METHODS: A prospective study to compare echocardiographic left ventricular diastolic wall thickness (> or =5 mm), low-dose dobutamine echocardiography and rest-redistribution thallium-201 scintigraphy, alone and in combination, for predicting recovery of left ventricular akinesis after surgical revascularization.
RESULTS: Twenty-eight consecutive patients aged 58+/-9 years were studied. Of the 448 left ventricular segments, 263 were akinetic at rest; 230/263 (87%) had wall thickness > or =5 mm, 135 (51%) had a positive response and 175 (66.5%) were graded viable on thallium. Of akinetic segments 61% improved after surgery. Left ventricular score decreased from 2.3+/-0.4 to 1.8+/-0.4 (P<0.01) and ejection fraction increased from 27+/-10 to 37+/-14% (P<0.01). For predicting results at 1 year, diastolic wall thickness had a sensitivity and a predictive accuracy of a negative test of 100% but a specificity of 28% and predictive accuracy of a positive test of 61%. The addition of dobutamine echocardiography or thallium-201 improved the predictive accuracy of a positive test to 76% and 69%, respectively; the addition of both tests was not of greater benefit than that of a single test.
CONCLUSIONS: Diastolic wall thickness <5 mm on echocardiography was the best simple and single predictor of non-recovery of left ventricular dysfunction. The addition of dobutamine echocardiography or thallium-201, but not both, was the best solution for predicting recovery of left ventricular dysfunction. In times of limited resources, these findings are important from a clinical point of view. Copyright 2000 The European Society of Cardiology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10952825     DOI: 10.1053/euhj.1999.2038

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  10 in total

1.  Multi-modality imaging for assessment of myocardial viability?

Authors:  Eliana Reyes
Journal:  Int J Cardiovasc Imaging       Date:  2007-06-22       Impact factor: 2.357

2.  Detection of myocardial viability by dobutamine stress echocardiography: incremental value of diastolic wall thickness measurement.

Authors:  T Zaglavara; T Pillay; H Karvounis; R Haaverstad; G Parharidis; G Louridas; A Kenny
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

3.  Direct epicardial mapping can differentiate hibernating from scarred myocardium: a validation study with 18F-FDG-PET.

Authors:  Christian Vahlhaus; Michael Schäfers; Hans-Jürgen Bruns; Frauke Janssen; Jörg Stypmann; Dieter Hammel; Hans H Scheld; Otmar Schober; Günter Breithardt; Thomas Wichter
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-10       Impact factor: 1.468

Review 4.  Myocardial viability in chronic ischemic cardiomyopathy: similarities and discordance of different diagnostic approaches.

Authors:  Gaby Weissman; Federico M Asch
Journal:  J Cardiovasc Transl Res       Date:  2008-12-31       Impact factor: 4.132

Review 5.  Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice.

Authors:  Shahbudin H Rahimtoola; Vasken Dilsizian; Christopher M Kramer; Thomas H Marwick; Jean-Louis J Vanoverschelde
Journal:  JACC Cardiovasc Imaging       Date:  2008-07

Review 6.  Nuclear cardiology and heart failure.

Authors:  Raffaele Giubbini; Elisa Milan; Francesco Bertagna; Fernando Mut; Marco Metra; Carlo Rodella; Maurizio Dondi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12       Impact factor: 9.236

7.  Prevalence of regional myocardial thinning and relationship with myocardial scarring in patients with coronary artery disease.

Authors:  Dipan J Shah; Han W Kim; Olga James; Michele Parker; Edwin Wu; Robert O Bonow; Robert M Judd; Raymond J Kim
Journal:  JAMA       Date:  2013-03-06       Impact factor: 56.272

8.  Clinical Significance of Late Enhancement and Regional Wall Remodeling Assessed by 3T Magnetic Resonance Imaging.

Authors:  Terje H Larsen; Marie Stugaard; Svein Rotevatn; Ottar Nygård; Jan Erik Nordrehaug
Journal:  Clin Med Insights Cardiol       Date:  2015-04-15

Review 9.  Myocardial phenotypes and dysfunction in HFpEF and HFrEF assessed by echocardiography and cardiac magnetic resonance.

Authors:  Bostjan Berlot; Chiara Bucciarelli-Ducci; Alberto Palazzuoli; Paolo Marino
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

Review 10.  Myocardial Viability: From Proof of Concept to Clinical Practice.

Authors:  Aditya Bhat; Gary C H Gan; Timothy C Tan; Chijen Hsu; Alan Robert Denniss
Journal:  Cardiol Res Pract       Date:  2016-05-29       Impact factor: 1.866

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.